Outcome of the first year of treatment for exudative age-related macular degeneration under a treatment programme using aflibercept - own experience.

STUDY OBJECTIVE: Anatomic and functional (function improvement) outcome of the aflibercept treatment for exudative age-related macular degeneration was analysed a er the first year of treatment.

MATERIAL AND METHODS: 62 patients treated with intravitreal aflibercept injections according to the adapted regimen. The treatment efficacy was understood as a reduction in oedema (and the central retinal thickness), with an increase in or stabilisation of the best corrected visual acuity.

RESULTS: In nearly all patients, a reduction in the central retinal thickness was observed, with stabilisation of or improvement in the best corrected visual acuity.

CONCLUSION: The aflibercept treatment for exudative age-related macular degeneration is a promising and efficient treatment method.